1. Home
  2. GAIN vs AURA Comparison

GAIN vs AURA Comparison

Compare GAIN & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAIN
  • AURA
  • Stock Information
  • Founded
  • GAIN 2005
  • AURA 2007
  • Country
  • GAIN United States
  • AURA United States
  • Employees
  • GAIN N/A
  • AURA N/A
  • Industry
  • GAIN Finance: Consumer Services
  • AURA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GAIN Finance
  • AURA Health Care
  • Exchange
  • GAIN Nasdaq
  • AURA Nasdaq
  • Market Cap
  • GAIN 497.5M
  • AURA 398.1M
  • IPO Year
  • GAIN 2005
  • AURA 2021
  • Fundamental
  • Price
  • GAIN $13.63
  • AURA $7.51
  • Analyst Decision
  • GAIN Hold
  • AURA Strong Buy
  • Analyst Count
  • GAIN 2
  • AURA 4
  • Target Price
  • GAIN $13.75
  • AURA $23.00
  • AVG Volume (30 Days)
  • GAIN 117.3K
  • AURA 143.9K
  • Earning Date
  • GAIN 02-12-2025
  • AURA 03-26-2025
  • Dividend Yield
  • GAIN 7.04%
  • AURA N/A
  • EPS Growth
  • GAIN N/A
  • AURA N/A
  • EPS
  • GAIN 1.92
  • AURA N/A
  • Revenue
  • GAIN $89,176,000.00
  • AURA N/A
  • Revenue This Year
  • GAIN $6.13
  • AURA N/A
  • Revenue Next Year
  • GAIN $8.54
  • AURA N/A
  • P/E Ratio
  • GAIN $7.11
  • AURA N/A
  • Revenue Growth
  • GAIN 6.78
  • AURA N/A
  • 52 Week Low
  • GAIN $12.46
  • AURA $6.63
  • 52 Week High
  • GAIN $14.85
  • AURA $12.38
  • Technical
  • Relative Strength Index (RSI)
  • GAIN 53.04
  • AURA 38.25
  • Support Level
  • GAIN $13.26
  • AURA $7.50
  • Resistance Level
  • GAIN $13.64
  • AURA $8.16
  • Average True Range (ATR)
  • GAIN 0.18
  • AURA 0.31
  • MACD
  • GAIN 0.02
  • AURA -0.02
  • Stochastic Oscillator
  • GAIN 52.56
  • AURA 1.30

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: